🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
230.26
-6.19 (-2.62%)
At close: Nov 20, 2026, 4:00 PM EST
230.62
+0.36 (0.16%)
After-hours: Nov 20, 2026, 7:30 PM EST

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Total Neuroscience Revenue
3.08B2.88B2.70B
Total Oncology Revenue
1.42B1.13B1.11B
Other Product Revenue
-14.17M11.47M
Total Product Revenue, Net
4.51B4.02B3.82B
High-Sodium Oxybate AG Royalty Revenue
172.60M211.73M217.58M
Other Royalty and Contract Revenue
35.18M34.01M30.21M
Total Royalties and Contract Revenue
207.78M245.74M247.79M
Revenue (Other)
60.00K--
Revenue (Total)
4.72B4.27B4.07B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
4.21B3.83B3.66B
Europe Revenue
374.42M341.12M312.71M
All Other Countries Revenue
130.99M94.87M96.14M
Revenue (Other)
60.00K--
Revenue (Total)
4.72B4.27B4.07B